Oncothyreon to Present at Wedbush Securities Life Sciences Management Access Conference PR Newswire SEATTLE, Aug. 6, 2013 SEATTLE, Aug. 6, 2013 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that Julie Eastland, Chief Financial Officer and Vice President, Corporate Development, will present at the Wedbush Securities Life Sciences Management Access Conference in New York on Tuesday, Aug. 13, 2013 at 1:55 p.m. Eastern. A live and archived webcast of the presentation will be accessible by visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section. About Oncothyreon Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com. SOURCE Oncothyreon Inc. Contact: Investor and Media Relations Contact: Julie Rathbun Rathbun Communications 206-769-9219 email@example.com
Oncothyreon to Present at Wedbush Securities Life Sciences Management Access Conference
Press spacebar to pause and continue. Press esc to stop.